Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.
2.

HIV-associated lipoatrophy: what are the kinder, gentler agents?

Dubé MP.

Clin Infect Dis. 2006 Jan 15;42(2):281-2. Epub 2005 Dec 5. No abstract available.

PMID:
16355342
3.

Pathogenesis and treatment of lipodystrophy: what clinicians need to know.

Sattler FR.

Top HIV Med. 2008 Oct-Nov;16(4):127-33. Review.

4.

Pathogenesis and management of lipoatrophy.

Tungsiripat M, McComsey G.

Curr HIV/AIDS Rep. 2008 May;5(2):55-63. Review.

PMID:
18510890
5.

[HIV lipodystrophy syndrome: a new challenge to the endocrinologist].

Valente O, Valente AM.

Arq Bras Endocrinol Metabol. 2007 Feb;51(1):3-4. Portuguese. No abstract available.

6.

Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.

Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.

Hum Pathol. 2009 May;40(5):705-13. doi: 10.1016/j.humpath.2008.09.019. Epub 2009 Jan 20.

PMID:
19157507
7.

HIV lipodystrophy: where are we after ten years?

Vergel N.

GMHC Treat Issues. 2007 Jul-Dec;21(3-4):10-5. No abstract available.

PMID:
19230305
8.

HIV and insulin resistance in context.

Kotler DP.

AIDS Read. 2005 May;15(5):220. No abstract available.

PMID:
15900630
9.

Management of morphologic changes associated with antiretroviral use in HIV-infected patients.

Wohl DA, Brown TT.

J Acquir Immune Defic Syndr. 2008 Sep 1;49 Suppl 2:S93-S100. doi: 10.1097/QAI.0b013e318186521a. Review.

PMID:
18725818
10.

What does the term "HIV-associated lipodystrophy" mean?

Marcason W.

J Am Diet Assoc. 2009 Feb;109(2):364. doi: 10.1016/j.jada.2008.12.005. No abstract available.

PMID:
19167963
11.

Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.

Bernardo A, Bianchi D, Magnaghi V, Minghetti L.

J Neuropathol Exp Neurol. 2009 Jul;68(7):797-808. doi: 10.1097/NEN.0b013e3181aba2c1.

PMID:
19535992
12.

Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.

Sievers M, Walker UA, Sevastianova K, Setzer B, Wågsäter D, Eriksson P, Yki-Järvinen H, Sutinen J.

J Infect Dis. 2009 Jul 15;200(2):252-62. doi: 10.1086/599986.

PMID:
19519254
13.

[Stigmatization, metabolic trouble, drug resistance: current challenges in HIV therapy].

Mauss S, Jablonowski H.

MMW Fortschr Med. 2009 Apr 30;151(18):28. German. No abstract available.

PMID:
19769068
14.

Peroxisome proliferator-activated receptor gamma agonists in kidney disease--future promise, present fears.

Mao Z, Ong AC.

Nephron Clin Pract. 2009;112(4):c230-41. doi: 10.1159/000224789. Epub 2009 Jun 16. Review.

15.

Disorders of body fat distribution in HIV-1-infected patients.

Moreno S, Miralles C, Negredo E, Domingo P, Estrada V, Gutiérrez F, Lozano F, Martínez E.

AIDS Rev. 2009 Jul-Sep;11(3):126-34. Review.

PMID:
19654854
16.

Stavudine in antiretroviral therapy: is this the end?

Brinkman K.

AIDS. 2009 Aug 24;23(13):1727-9. doi: 10.1097/QAD.0b013e32832d3c5e. No abstract available.

PMID:
19571724
17.

Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.

Xiao J, Leung JC, Chan LY, Guo H, Lai KN.

Nephrol Dial Transplant. 2009 Jul;24(7):2067-77. doi: 10.1093/ndt/gfn746. Epub 2009 Jan 20.

PMID:
19155534
18.

Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.

Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, Febbraro A, Colantuoni V.

Hum Pathol. 2009 May;40(5):714-25. doi: 10.1016/j.humpath.2008.08.019. Epub 2009 Jan 3.

PMID:
19121846
19.

[Side effects of antiretroviral therapy--skin manifestations].

Esser S.

MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:8, 10-1. Review. German. No abstract available.

PMID:
19024907
20.

INT131: a selective modulator of PPAR gamma.

Motani A, Wang Z, Weiszmann J, McGee LR, Lee G, Liu Q, Staunton J, Fang Z, Fuentes H, Lindstrom M, Liu J, Biermann DH, Jaen J, Walker NP, Learned RM, Chen JL, Li Y.

J Mol Biol. 2009 Mar 13;386(5):1301-11.

PMID:
19452630

Supplemental Content

Support Center